IVVD vs LEN · rev $53.4M vs rev $34.19B
Invivyd Inc. (IVVD) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Invivyd Inc. (IVVD) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported IVVD revenue for 2025-12-31 was $53.4M. Net income was -$52.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. IVVD currently screens at market cap $85.8M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
IVVD currently screens at market cap $85.8M. LEN currently screens at market cap $0.
Not investment advice. Open the IVVD and LEN stock pages for the full models.
Not investment advice.